Area of research
Infectious Diseases · Economics and Econometrics
Research interest
Research interests include Medicine, Tuberculosis, Psychological intervention, Environmental health, Activity-based costing, and Regimen.
Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation
Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysis
Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis
Safe inhalation pipe provision (SIPP): protocol for a mixed-method evaluation of an intervention to improve health outcomes and service engagement among people who use crack cocaine in England
Uncertainty in tuberculosis clinical decision-making: An umbrella review with systematic methods and thematic analysis
Estimating the health and macroeconomic burdens of tuberculosis in India, 2021–2040: A fully integrated modelling study
Improving hospital-based opioid substitution therapy (iHOST): protocol for a mixed-methods evaluation
Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
Improving hospital-based opioid substitution therapy (iHOST): protocol for a mixed-methods evaluation
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial
A Scoping Review and Taxonomy of Epidemiological-Macroeconomic Models of COVID-19
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries
Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countries
Costs of TB services in India (No 1)
Cost of TB services in healthcare facilities in Kenya (No 3)
Cost of TB services in the public and private sectors in Georgia (No 2)
Post-tuberculosis mortality and morbidity: valuing the hidden epidemic
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology
Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa
Evaluating the cost‐effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs
Meta-analysis of average costs of HIV testing and counselling and voluntary medical male circumcision across thirteen countries
Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial